Novel subgroups of patients with adult-onset diabetes in Chinese and US populations

In The Lancet Diabetes & Endocrinology, Emma Ahlqvist and colleagues1 used six variables to identify five exclusive diabetes subgroups, which were verified by distinct progression trajectories of microvascular complications. However, since all cohorts tested were from registry-based northern European studies, the utility of this new classification in Chinese and US populations is unclear.